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Objectives: to assess the quality of life after successful intervention among patients with varying degrees of lower-limb
ischaemia in comparison with healthy controls and the respondents’ degree of sense of coherence.
Materials and methods: one hundred and twelve patients and 102 healthy controls were assessed for quality of life
(Nottingham Health Profile) and sense of coherence.
Main results: successful angioplasty or surgical intervention led to an improved quality of life at 6 months, in particular
with regard to pain, sleep, physical mobility, hobbies and holiday and to a level similar to healthy controls in sleep, social
isolation, paid employment and family relationships. It remained at a significantly lower level than that of healthy controls
with regard to pain, emotional reactions, physical mobility, energy, housework, hobbies, holidays, sex and social life.
Critical ischaemia patients did not reach the same level of quality of life as the claudicants or the healthy controls.
Conclusion: successful treatment for chronic limb ischaemia improved the quality of life significantly, more so in
claudicants than in patients with critical ischaemia. The degree to which the quality of life improved was associated with
the patients’ sense of coherence and their ankle pressure.
Key Words: Quality of life; Nottingham Health Profile; Sense of coherence; Intermittent claudication; Critical ischaemia;
Bypass; Percutaneous transluminal angioplasty; Outcome; Effect size.
Introduction of intervention has any impact on the patients’ life
quality or if the effect is only related to the severity
The increasing number of lower-limb ischaemia of the disease.
patients undergoing arterial reconstruction and per- The success of the outcome may be expressed in
cutaneous transluminal angioplasty (PTA),1 calls for a terms of survival rates and graft patency,4 but also in
broader understanding of the outcome. Lower-limb terms of improvements in quality of life. The degree
ischaemia is a common problem which, left untreated, of ischaemia and the choice of intervention may in-
markedly affects patients’ quality of life.2 It is also fluence the recovery process and represent important
known that quality of life deteriorates with in- considerations in predicting the outcome. Previous
creasingly severe lower-limb ischaemia.3 However, less quality-of-life studies have shown improvements by
is known about how interventions affect patients’ qual- analysing the impact of a specific degree of ischaemia,
ity of life. or following one specific intervention.5,6 However, no
In lower-limb ischaemia patients, the purpose of study has previously analysed the influence of these
treatment is primarily directed at symptomatic relief factors on the outcome by reflecting the whole spec-
and thus to improve quality of life. There are several trum of the disease and the various interventions
intervention options available involving various endo- applied.
vascular techniques such as PTA or open surgical Other factors than the degree of ischaemia and
reconstruction. These interventions have their ad- the type of intervention may influence the patients’
vantages and drawbacks. It is not known if the type perception of the success of the treatment such as their
sense of coherence (SOC).7 Recently, several studies
have reported a relationship between a person’s sense
* Please address all correspondence to: R. Klevsga˚rd, Centre of of coherence and his or her quality of life.8,9 A personCaring Sciences, Lund University, P.O. Box 198, SE-22100 Lund,
Sweden. with a strong sense of coherence tends to manage
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stressful life situations more successfully and stays distance (ACD). The severity of patients’ ischaemia
was graded according to suggested standards for re-well, whereas those with a weak sense of coherence
tend to be more vulnerable to reduced well-being porting grade of lower limb ischaemia.10 Data con-
cerning medical condition were collected fromwhen falling ill. Little attention has been directed
towards the influence of a patient’s sense of coherence patients’ medical records.
For comparison, 117 healthy controls were recruitedwhen assessing the outcome of vascular surgery. Thus,
when assessing quality of life following a particular from a local population study.11 The purpose of the
population study was to collect reference values insuccessful intervention it should not only be based on
improvements in lower-limb perfusion, but also on clinical chemistry and the sampling followed the cri-
teria for selecting healthy references according to SCRVthe influence of the degree of ischaemia, type of inter-
vention and the patient’s sense of coherence. (Scandinavian Committee on Reference Values).12,13
Thus, individuals having no diagnosed disease, noThe aim of this study was to assess the effects on
quality of life 6 months after successful angioplasty consumption of drugs, normal clinical chemical values,
normal blood pressure and normal weight were eli-or surgical reconstruction among patients with varying
degrees of lower-limb ischaemia in comparison with gible for inclusion and had been called for medical
examination regularly since 1963. For this study 102healthy controls and in relation to the respondents’
degree of sense of coherence. (87%) individuals were included from the 1995 follow-
up. They were consecutively selected and no matching
was performed.3
Materials and Methods
Quality of life assessment
Patients
The Nottingham Health Profile (NHP)14 was used to
determine patients’ quality of life. The NHP was de-One hundred and twelve consecutive patients with
varying degrees of ischaemia were found to have rived from the earlier Nottingham Health Index
(NHI)15 and designed as a measure of perceived healthsuccessful revascularisation 6 months after inter-
vention. The criterion for successful improvement was problems (part I) and their effects on activities in daily
living (part II). Part I consists of 38 weighted scoresan ankle–brachial pressure index (ABPI) [0.15 fol-
lowing treatment.10 Sixty-seven (60%) patients had in six dimensions: energy, pain, emotional reactions,
sleep, social isolation and physical mobility.16 Possibleintermittent claudication and 45 (40%) had critical
ischaemia. These patients were recruited from 168 scores for each dimension range from zero to 100, a
higher score reflecting greater perceived health prob-patients referred for intervention at the vascular sur-
gical units in three counties in southern Sweden.3 Fifty lems. The total NHP score represents the summed
range score of the answers in part I of the NHP. Part(30%) of these patients were excluded from the analysis
(n=34), because they did not fulfil the inclusion criteria II of the profile consists of seven areas of daily living
related to: paid employment, housework, family re-on basis of improvement, had undergone major am-
putation (n=8) or had died (n=8). Six (5%) patients lationships, sex life, social life, hobbies and holidays,
and these are presented as affirmative responses. Thedid not wish to participate in the study at this stage.
Thus the response rate was 95%. Four different treat- NHP instrument was chosen because at that time,
when the study was planned, it was the only in-ment modalities were used; 58 (52%) were treated
using PTA alone, 43 (38%) had a surgical bypass graft, strument which provided comparative data. Previous
studies using the NHP scale showed high reliabilityone had a patch and 10 (9%) patients had a surgical
thromboendarterectomy (TEA). Most of the clau- with alpha values of the total NHP (0.87), emotion
(0.81), pain (0.72), sleep (0.68) and energy (0.57), butdicants 42 (63%) were treated with PTA, while 29
(64%) of the critical ischaemia patients were treated less consistent regarding social isolation (0.34) and
mobility (0.39) in patients with arthritis of the hipwith a surgical bypass.
On admission to hospital and 6 months after inter- joint.17 High validity was also shown by its ability to
discriminate well-being in normotensives from that ofvention, a routine medical history was obtained and
clinical examinations performed including ankle– hypertensives compared to other scales.18
In addition to the NHP questionnaire, patientsbrachial pressure (ABP) and ABPI. Claudicants were
submitted to a standard treadmill test at 3 km/hour responded to the SOC questionnaire.19 The SOC
comprises three components: comprehensibility, man-with a 14% inclination measuring the initial clau-
dication distance (ICD) and the absolute claudication ageability and meaningfulness. An individual’s sense
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of coherence is believed to be a prerequisite to coping.7 performed on the statistical package SPSS 8.0 for over-
all comparison and a p-value of <0.05 was taken asThus it may also be a moderating variable when
measuring life quality in relation to a disease and its statistically significant.25
treatment. Each item is answered by selecting agree-
ment or disagreement with given statements on a scale
from one to seven. The shorter version comprises 13
Resultsitems with a possible scoring range from 13 to 91. The
higher the score, the stronger the sense of coherence.
There were significant improvements in ABPI for bothThe mean SOC score in a healthy sample was found
claudicants and critical ischaemia patients (p<0.0001)to be 61 (s.d. 9).20 Upon admission to the hospital,
and in walking distance for claudicants (p<0.0001)patients had given prior consent to participate in the
after intervention (Table 1). No significant differencestudy. Patients were asked to fill out the NHP and SOC
was found in the SOC from the baseline compared toquestionnaires by themselves, before the intervention
the 6-month follow-up (Table 1). ABPI at the follow-and 6 months later. The healthy controls were asked
up correlated significantly with mobility (r=-0.25,for informed consent at the regular examination and
p<0.008), pain (r=-0.27, p<0.005), energy (r=-0.20,had their questionnaires sent home to them afterwards.
p<0.04) and the total NHP (r=-0.24, p<0.01). WalkingThe study was approved by the Ethical Committee of
distance for claudicants correlated significantly withLund University.
mobility (r=-0.33, p<0.006), pain (r=-0.25, p<0.03),
energy (r=-0.25, p<0.04) and the total NHP (r=
-0.28, p<0.02). The SOC correlated significantly with
the total NHP score in the group as whole (r=-0.51,Statistics
p<0.0001).
The total NHP before intervention was significantlyDifferences in quality-of-life scores at the baseline and
6 months later for part I of the NHP between patients higher among patients than among healthy controls,
22 (q1 11.6–q3 38.2) and 2 (q1 0.0–q3 8.8) respectivelyand healthy controls were tested using the Mann–
Whitney U-test. For differences in NHP part II the (p<0.0001), indicating a lower quality of life in the
patients. All health dimensions in part I of the NHPChi-squared test was used. The changes in quality-of-
life score after angioplasty or surgical intervention showed significantly lower quality of life in the
patients and significantly more problems in all areaswere analysed by the Wilcoxon signed-ranks test for
part I and by the McNemar test for part II. An effect of activities in daily living (part II) compared to the
healthy controls, with the exception of paid em-size was calculated for each dimension of the NHP by
dividing the difference between pre-treatment and ployment (Table 2). Patients with critical ischaemia
had significantly higher scores with regard to painpost-treatment median values by the interquartile
range at the baseline.21 An effect size of 0.20 is reported (p<0.001) and reduced physical mobility (p<0.04) as
well as more problems in the area of houseworkto be small, 0.50 moderate and 0.80 or greater to be
large.22 Logistic regression analysis, with the forward (p<0.04) than patients with claudication only.
All health dimensions improved significantly for thestepwise method, was used to determine factors of
importance for high quality of life (total NHP score claudicants after intervention (Fig. 1). Patients with
critical ischaemia showed significant improvements in<1.85, 25th percentile). Sex, age (<68> mean years),
ABPI (<0.90> mean score), SOC (<74.4> mean score), pain, sleep and physical mobility (Fig. 2). Significant
improvements were also found in all areas of dailypatients treated with PTA/surgery and patients suf-
fering from claudicatio intermittens/critical ischaemia living (part II) for patients with claudication except
for the area of sex life, while patients with criticalwere variables included in the analysis.23 The cor-
relation between the NHP scores, ankle pressure and ischaemia showed improvements in the area of hobbies
and holidays (Fig. 3). Patients with critical ischaemiawalking distance was analysed using Spearman’s rank-
correlation test. Internal consistency for each scale was reported significantly more problems with pain
(p<0.02), physical mobility (p<0.004), work (p<0.03)measured using Cronbach’s alpha.24 The domains in
the NHP showed a high level of internal consistency and housework (p<0.001) than patients with clau-
dication. Quality of life improved significantly amongregarding pain (r=0.84), emotional reactions (r=0.80),
energy and physical mobility (r=0.75), sleep (r=0.67) claudicants treated with PTA with regard to pain
(p<0.0001), emotional reactions and physical mobilityand moderate internal consistency regarding social
isolation (r=0.60). An analysis of the SOC scale (p<0.001), the total NHP (p<0.0001), energy (p<0.01)
and social isolation (p<0.02). For those treated withshowed an alpha value of 0.85. Data analysis was
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Table 1. Demographic details and the sense of coherence in the patient groups and healthy control.
Claudicants Critical ischaemia Healthy controls
n=67 n=45 n=102 p-Value
Age Md (q1, q3)1 68.0 (59.0–72.0) 72.0 (65.5–79.5) 61.0 (52.0–70.0) 0.001a,b,c
Sex2
Male/female 35/32 27/18 57/45 0.6
SOC Md (q1, q3)
Before intervention1 78.0 (65.0–83.0) 75.0 (61.5–80.0) 76.0 (68.0–82.0) 0.5
After intervention3 74.0 (65.7–85.0) 75.0 (63.0–86.5) 0.6
Differences before and after, 0.05 0.3
p-value4
Severity of disease Md (q1,q3)
ABPI before treatment 0.6 (0.4–0.7) 0.4 (0.3–0.5)
ABPI after treatment3 0.9 (0.8–1.02) 0.8 (0.7–1.0) 0.04
Differences before and after, 0.0001 0.0001
p-value4
ACD before treatment in metres 137.1 (74.2)
ACD after treatment 307.1 (259.9)
Differences before and after, 0.0001
p-value4
1 Tested by Kruskal–Wallis test, 2 Chi-squared test, 3 Mann–Whitney U-test, 4 Wilcoxon signed-ranks test.
a Healthy controls versus claudicants, b healthy control versus critical ischaemia, c claudicants versus critical ischaemia.
Differences between pairs of groups were tested by Mann–Whitney U-test.
Table 2. Median scores in NHP part I and number of problems with daily activities





Energy 23.8 (0.0–63.2) 0.0 (0.0–0.0) 0.0001
Pain 32.3 (18.5–66.4) 0.0 (0.0–0.0) 0.0001
Emotional reactions 7.9 (0.0–28.3) 0.0 (0.0–0.0) 0.0001
Sleep 11.1 (0.0–55.7) 11.1 (0.0–11.1) 0.0001
Social isolation 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.01
Physical mobility 20.3 (10.2–38.6) 0.0 (0.0–0.0) 0.0001
Part IIb
Paid employmentc 11 (9.8) 6 (5.9) 0.09
Housework 56 (50) 14 (13.7) 0.0001
Family relationships 19 (17) 1 (1) 0.0001
Social life 33 (29.5) 7 (6.9) 0.0001
Sex life 28 (25) 6 (5.9) 0.0001
Hobbies 56 (50) 9 (8.8) 0.0001
Holidays 59 (52.7) 8 (7.8) 0.0001
a Mann–Whitney U-test. Median value (25th and 75th percentile). A high score indicates
more perceived problems.
b Tested by Chi-squared test. Nos experiencing problem (%).
c Analysis includes 24 patients.
surgery, improvements were observed in the total treated with PTA and surgery, except for the fact that
claudicants treated with PTA had fewer problemsNHP (p<0.0001), pain (p<0.001), physical mobility and
sleep (p<0.002) and energy (p<0.04). Critical ischaemia with regard to social isolation than those treated with
surgery (p<0.04) and that critical ischaemia patientspatients treated with surgery displayed significant
improvements in pain (p<0.0001), the total NHP treated with surgery had fewer problems regarding
energy (p<0.04) and physical mobility (p<0.04) than(p<0.001), sleep (p<0.002) and physical mobility
(p<0.01), while those treated with PTA showed im- those treated with PTA.
The effect-size 6 months after intervention could beprovements in sleep (p<0.003), pain (p<0.004), and
the total NHP (p<0.02). There were no significant regarded as large in physical mobility (0.91) and social
isolation (1.31) among claudicants, while the effect-sizedifferences in NHP scores between the subgroups
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Fig. 3. The percentage of responses reporting problems affecting
their daily lives, part II of the NHP, before and after intervention






















*=p<0.05, **=p<0.01 McNemar test.
Fig. 1. Median score in NHP part I beforeR and afterF intervention
in claudicants (n=67). *=p<0.05, **=p<0.01, ***=p<0.001 Wil-
coxon signed-ranks test.
equally good quality of life) regarding sleep, social
isolation, paid employment and family relationships
(Table 4). The total NHP score was still significantly
higher (worse quality of life) among patients than
among the healthy controls, 9 (q1 1.9–q3 22.5) and 2 (q1
0.0–q3 8.8) respectively (p<0.0001). Significantly higher
scores were found among patients regarding pain,
restriction in mobility, emotional reactions and energy
than in the healthy control group. Patients also ex-
perienced significantly more problems with house-
work, hobbies, holidays, sex life and social life
compared to the healthy controls (Table 4).
Logistic regression analysis showed that a high sense
of coherence (odds ratio (OR): 3.3, confidence interval
(CI): 1.3–8.3, p<0.01) and a high ankle–brachial pres-
sure index after intervention (OR: 2.6, CI: 1.0–6.5,
p<0.04) was significantly associated with low total
NHP scores, indicating high quality of life after inter-


















to the claudicant or critical ischaemia group were
Fig. 2. Median score in NHP part I beforeR and afterF intervention factors not significantly associated with low total NHP
in critical ischaemia patients (n=45). **=p<0.01, ***=p<0.001
scores.Wilcoxon signed-ranks test.
for critical ischaemia patients was large in emotional
reactions, sleep, and social isolation ranging from 0.86 Discussion
to 2.03 (Table 3). Angioplasty in claudicants resulted
in a large effect-size ranging from 0.84 to 1.74 in The main findings of this study were that successful
angioplasty or surgical intervention led to improvedemotional reactions, energy, physical mobility, pain
and social isolation and, in critical ischaemia patients quality of life at 6 months, especially regarding pain,
sleep, physical mobility, hobbies and holiday. Patients’treated with surgery, in emotional reactions, energy,
sleep and social isolation (0.90–1.90). quality of life was restored to a level similar to that
of healthy controls regarding sleep, social isolation,After intervention, the NHP scores of patients were
similar to those of the healthy controls (suggesting paid employment and family relationships, whereas
Eur J Vasc Endovasc Surg Vol 19, March 2000
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Table 3. Effect sizes 6 months after angioplasty and surgery for part I of the NHP for selected groups.
Total Claudicants Total Critical ischaemia
Angioplasty Surgery Angioplasty Surgery
Dimension n=67 n=42 n=25 n=45 n=16 n=29
Energy 0.39 (n=38) 0.96 (n=19) 0.96 (n=17) 0.62 (n=24) 0.69 (n=10) 0.95 (n=14)
Pain 0.76 (n=66) 1.11 (n=41) 0.63 (n=25) 0.54 (n=44) 0.97 (n=16) 0.52 (n=28)
Emotional reactions 0.68 (n=38) 0.84 (n=26) 0.44 (n=12) 0.86 (n=24) 0.50 (n=8) 0.90 (n=16)
Sleep 0.47 (n=41) 0.21 (n=22) 0.80 (n=19) 0.93 (n=34) 1.05 (n=13) 1.34 (n=21)
Social isolation 1.31 (n=14) 1.74 (n=8) 1.61 (n=6) 2.03 (n=7) 0.00 (n=3) 1.90 (n=4)
Physical mobility 0.91 (n=57) 0.99 (n=35) 0.66 (n=22) 0.39 (n=40) 0.13 (n=15) 0.68 (n=25)
NHP total 0.46 0.61 0.76 0.56 0.16 0.63
Effect size is calculated by dividing the difference between pre-treatment and post-treatment median values by the interquartile range at
baseline (Kazis, 1989).
Table 4. Median scores in NHP part I and number of problems with daily activities





Energy 0.0 (0.0–36.8) 0.0 (0.0–0.0) 0.003
Pain 10.9 (0.0–29.4) 0.0 (0.0–0.0) 0.0001
Emotional reactions 0.0 (0.0–16.3) 0.0 (0.0–0.0) 0.0001
Sleep 11.1 (0.0–33.7) 11.1 (0.0–11.1) 0.24
Social isolation 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.07
Physically mobility 10.2 (0.0–30.9) 0.0 (0.0–0.0) 0.0001
Part IIb
Paid employmentc 2 (1.8) 6 (5.9) 0.24
Housework 42 (37.5) 14 (13.7) 0.0001
Family relationships 5 (4.5) 1 (1) 0.21
Social life 20 (17.9) 7 (6.9) 0.02
Sex life 25 (22.3) 6 (5.9) 0.001
Hobbies 33 (29.5) 9 (8.8) 0.0001
Holidays 31 (27.7) 8 (7.8) 0.0001
a Mann–Whitney U-test. Median value (25th and 75th percentile). A high score indicates
more perceived problems.
b Tested by Chi-squared test. Nos experience problem (%).
c Analysis includes 24 patients.
the areas of pain, emotional reactions, physical mo- assessed by using each patient as their own control.
This design is known to be effective in ensuring equi-bility, energy, housework, hobbies, holidays, sex and
social life did not improve to the same extent. Critical valence between groups being compared and thus
any bias in the treatment modality selected for anyischaemia patients showed a lower quality of life and
did not reach the same level as the claudicants or the particular patient may be eliminated. Secondly, the
degree of restored quality of life was determined byhealthy controls. The degree to which the quality of
life improved was seen to be an interplay between the using healthy controls for comparison. The demo-
graphic variables did not differ at the baseline betweenpatients’ sense of coherence and their ankle pressure.
The validity of clinical studies is vulnerable to threats patients and the healthy controls, with the exception of
age.3 However, age showed no significant associationof various types.26 The internal validity and thus the
external validity might be threatened in terms of dif- with the improved quality of life. Thirdly, the risk of
sample selection bias was reduced by selecting patientsferences in age between the groups, the effect of events
taking place during the intervening 6 months, mor- consecutively with clear entry criteria. Since the quality
of life is a subjective phenomenon the risk for in-tality because of old age and severe illness. Selection
biases may also affect the outcome when patients are formation bias in this study was avoided by excluding
patients unable to fill out the questionnaire by them-not assigned randomly. Several steps have been taken
to counteract the threats to the internal validity of this selves. This does, however, also limit generalisability
to those patients with more severe ischaemia.study. Firstly, changes in quality of life over time were
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There are two types of quality-of-life instruments, EuroQol, Chetter et al. assessed claudicants treated
with angioplasty and reported the median effect-sizesdisease-specific and generic. Specific instruments have
the focus on problems associated with a specific dis- at 6 months for physical function and pain to be
approximately 0.50 and 0.30 respectively.34 By usingease, while generic instruments provide a summary of
effect-size to demonstrate change after intervention, itgeneral health status, functional status and/or general
becomes possible to make comparisons between stud-quality of life.27 The Swedish version of the NHP scale
ies where different quality-of-life instruments are used.is generally agreed to be one of the best evaluated of
The poor distinction in quality of life between thethe generic quality-of-life instruments28 and has been
groups could be explained by the patient groupsused among patients with arthritis of the hip joint17
studied being too small or that the quality of life isand hypertension.18 The main limitation with regard
not due to a specific intervention. This interpretationto the sensitivity of the scale is, however, the “floor
was confirmed in the logistic regression analysis.effect”. In this study, this was seen in the social isolation
The results indicated that high SOC was one pre-factor, particularly in mild claudication cases, i.e. their
dictor associated with a high quality of life after inter-initial score was the lowest possible, making im-
vention. The quality of life was more stronglyprovements difficult to obtain. Despite the lack of
correlated to the sense of coherence than to any othervariations, in the area of social isolation, the scale was
variable studied. This supports Antonovsky’s sug-sensitive enough to identify significant changes among
gestion that the perception of health is related to theclaudicants. This interpretation was further supported
SOC7,19 and is also in line with other studies. Motzerwhen effect-size was calculated. The shorter SOC scale
et al.8 and Burckhart et al.9 reported SOC, social supporthas previously also showed a high level of reliability
and self-esteem to be predictors of quality of lifewith high alpha values in various studies (0.74–0.91)29
in individuals suffering from chronic illnesses. Thus,and alpha values of 0.77 in a Swedish sample.20 Ana-
quality of life is not merely a result of the severity oflyses in the present study indicated an alpha value of
the disease, as even patients with severe mobility0.85, which further emphasises the reliability of the
limitation can still obtain a good quality of life. Thisinstrument.
finding suggests that the quality of life outcome is notThe patients’ quality of life did not reach the same
only concerned with the ability to save an ischaemiclevel as the healthy controls in variables such as pain,
limb, but also with supporting individual patients.physical mobility, emotional reactions and energy. This
A high ABPI was another factor associated withis not an unexpected finding, since earlier studies have
high quality of life. In contrast, Whyman et al.5 reportedshown that the grade of the disease is an important
no correlation between improved ABPI, walking dis-independent predictor for low quality of life.3,30 Among
tance and quality-of-life score at 6 months, exceptpatients with severe ischaemia, Albers et al.31 and
with regard to pain among claudicants treated withGibbons et al.32 reported no changes in general health
angioplasty. Similar results have been demonstratedrating after revascularisation at 3- and 6-month follow-
by Currie et al.33 among claudicants after angioplastyups. The reason for this might be that 6 months is too
or surgical reconstruction. The haemodynamic successshort a time for recovery and that these patients may
following intervention had a favourable influence onstill require walking rehabilitation and nursing care
the patients’ quality of life in terms of less pain andfor non-healing ulcers. The effect of bilateral disease
sleep and improved mobility in both patient groupsmight be another explanation of the absence of the
studied. This finding underlines the need for con-total rehabilitation. These findings emphasise the need
sidering health-related quality of life as a further para-for further investigations in the assessment of quality
meter when assessing the outcome of interventionof life in long-term follow-up studies to determine the
both for claudicants and critical ischaemia patients.extent to which further improvement occurs or to
In conclusion, successful treatment for chronic limbwhich the benefits are maintained.
ischaemia improved the quality of life significantly,In terms of effect-size, the improvements in quality
more so in claudicants than in patients with criticalof life after 6 months’ intervention were largest in
ischaemia. The degree to which the quality of lifeclaudicants treated with angioplasty and for critical
improved was associated with the patients’ sense ofischaemia patients treated with surgery especially in
coherence and their ankle pressure.terms of energy, pain, emotional reactions, sleep, social
isolation and physical mobility. However, some of
Referencesthese dimensions showed effect-sizes below 0.20, in-
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